NOS2 and Alzheimer disease: Removal of iNOS in transgenic AD mice, or the use of iNOS inhibitors such as l-NAME (i.e., a general NOS inhibitor) or 1400 W (i.e., a specific iNOS inhibitor), results in improved behavioral dysfunction and protection against Aβ neurotoxicity in models of AD53,54.